Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Robert G. Harrell who wrote (1433)	12/8/1999 9:29:00 AM
From: Dean M. Kenley	Read Replies (2) \| Respond to of 1754

Should be back to $80 by the end of week. I picked some up at close yesterday @52.5 Best opportunity out there today even at these levels.

To: Robert G. Harrell who wrote (1433)	12/8/1999 1:22:00 PM
From: capitalistbeatnik	Read Replies (2) \| Respond to of 1754

NIDEK will be dead long before patent court. Their business plan, to make money selling machines while risking triple damages and service when the market leader can practically give them away, is suicidal. I don't know where they are coming from, but it is a good thing they are private. Bought more yesterday at 52. In the end all of this is a nonevent. VISX has early mover advantage and the leadership to make the run last. NIDEK will be a distant memory in a few years. Any doc stupid enough to risk his practice by buying a NIDEK deserves to lose everything.